Molecular mechanisms and therapeutic strategies for the recurrent F9 (c.520 + 13 A > G) variant in hemophilia B
This study elucidates the molecular mechanism of the F9 c.520 + 13 A > G variant, which activates a cryptic 5' splice site in intron 5, leading to an in-frame FIX (p.V174delinsGHNLM) with secretion defects and loss of protein function. And Engineered U1snRNA partially rescued the splicing defect.
Authors
- C Wang
- Dario Balestra (ORCID: https://orcid.org/0000-0002-6675-9429)
- Meixiu Gu
- Zhimin Meng
- Huayang Zhang (ORCID: https://orcid.org/0000-0001-5207-8932)
- W. Guo
- Weitao Zhang (ORCID: https://orcid.org/0009-0003-2014-6314)
- Yichao Guo
- Beili Wang
Institutions
- University of Ferrara (IT)
- Fudan University (CN)
- Shanghai Medical Information Center (CN)
- Zhongshan Hospital of Xiamen University (CN)
- Zhongshan Hospital (CN)
- YangPu Geriatric Hospital (CN)
Publication Details
- Journal
- Human Genomics
- Published
- 2026-01-08
- DOI
- https://doi.org/10.1186/s40246-025-00890-y
- Primary Topic
- Hemophilia Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00